Xtant Announces Preliminary Third Quarter 2015 Revenue
October 13, 2015 07:30 ET
|
Xtant Medical Holdings, Inc.
Third Quarter 2015 Pro Forma Combined Revenue in the range of $20.7 million to $20.9 million, an increase of 5.5 % to 6.5 % over the same period last yearExcluding OEM Revenue, Third Quarter 2015...
Xtant(TM) Medical Exhibits at North American Spine Society (NASS) Meeting
October 12, 2015 13:13 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Oct. 12, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), a leader in the development of regenerative medicine products and medical devices, today announced...